EW
BIOX icon

Evoke Wealth’s Bioceres Crop Solutions BIOX Stock Holding History

Evoke Wealth’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,100
Closed -$40K – 453
2022
Q3 		$40K Buy
+3,100
New +$38.1K ﹤0.01% 548

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Evoke Wealth's BIOX Position: Q4 2022 in Review

Evoke Wealth sold out of Bioceres Crop Solutions (BIOX) in Q4 2022, closing a stake of 3,100 shares — an estimated $40K sold.

Evoke Wealth first reported a position in BIOX in Q3 2022 and held it in 1 quarter. The position peaked at $40K in Q3 2022. 50 funds tracked by Wall St. Rank hold BIOX as of Q4 2022.

  • Evoke Wealth reported no remaining Bioceres Crop Solutions position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 3,100 Bioceres Crop Solutions shares in Q4 2022, an estimated $40K.
  • Evoke Wealth first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 1 quarter.
  • Evoke Wealth's Bioceres Crop Solutions position peaked at $40K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.